Seeing Is Believing
Currently out of the existing stock ratings of Chris Schott, 9 are a SELL (4.31%), 54 are a HOLD (25.84%), 146 are a BUY (69.86%).
Analyst Chris Schott, currently employed at JPMORGAN, carries an average stock price target met ratio of 42.37% that have a potential upside of 21.1% achieved within 260 days.
Chris Schott’s has documented 416 price targets and ratings displayed on 30 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ELAN, Elanco Animal Health at 06-Oct-2025.
Analyst best performing recommendations are on EQRX (EQRX).
The best stock recommendation documented was for EQRX (EQRX) at 8/16/2022. The price target of $5.5 was fulfilled within 3 days with a profit of $0.67 (13.87%) receiving and performance score of 46.24.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$284
$53.5 (23.21%)
$220
2 days ago
(10-Oct-2025)
43/44 (97.73%)
$53.5 (23.21%)
593
Hold
$251
$20.5 (8.89%)
$205
9 days ago
(03-Oct-2025)
15/16 (93.75%)
$17.09 (7.31%)
300
Buy
$270
$39.5 (17.14%)
$195
25 days ago
(17-Sep-2025)
2/3 (66.67%)
$49.19 (22.28%)
121
Buy
$235
$4.5 (1.95%)
$200
26 days ago
(16-Sep-2025)
14/14 (100%)
$18.74 (8.67%)
483
Buy
$245
$14.5 (6.29%)
$210
27 days ago
(15-Sep-2025)
16/17 (94.12%)
$27.39 (12.59%)
244
Which stock is Chris Schott is most bullish on?
Which stock is Chris Schott is most reserved on?
What Year was the first public recommendation made by Chris Schott?